Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: evidence of a potentially relevant species-specific interaction with diet-Reference-Cited by-同舟云学术

Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: evidence of a potentially relevant species-specific interaction with diet

Published:1998-02 Issue:2 Volume:39 Page:457-462
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Escolà-Gil Joan Carles,Marzal-Casacuberta Àfrica,Julve-Gil Josep,Ishida Brian Y.,Ordóñez-Llanos Jordi,Chan Lawrence,González-Sastre Francesc,Blanco-Vaca Francisco

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference22 articles.

1. High density lipoproteins, reverse transport of cholesterol, and coronary artery disease. Insights from mutations;Assmann;Circulation,1993

2. Heterogeneity of high density lipoprotein particles;Fruchart;Circulation,1993

3. Mouse models of atherosclerosis;Breslow;Science,1996

4. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice;Schultz;Nature,1993

5. The properties of HDL in genetically engineered mice;Schultz;Curr. Opin. Lipidol.,1994

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review;Journal of Lipid Research;2014-10

2. Human Apolipoprotein A-II Protects Against Diet-Induced Atherosclerosis in Transgenic Rabbits;Arteriosclerosis, Thrombosis, and Vascular Biology;2013-02

3. Enhancement of HDL Formation and Normalization of Intravascular HDL Remodeling;High-Density Lipoproteins;2011-11-28

4. ApoA-I deficiency in mice is associated with redistribution of apoA-II and aggravated AApoAII amyloidosis;Journal of Lipid Research;2011-08

5. Apolipoprotein A-II: Evaluating its significance in dyslipidaemia, insulin resistance, and atherosclerosis;Annals of Medicine;2011-04-18